Allergen-specific T lymphocyte

An **allergen-specific T lymphocyte** is a T cell that recognizes and responds to a particular allergen-derived peptide presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells[1][3][5]. These cells include various subtypes such as helper (CD4+), regulatory (Treg), cytotoxic (CD8+), and γδ T cells, each playing distinct roles in allergic responses, tolerance induction, and immunopathology[2][4][5]. In allergies, allergen-specific T helper (Th2) cells drive IgE production and inflammation through cytokines like IL-4, IL-5, and IL-13, while regulatory T cells can suppress these responses but may be dysfunctional in allergic diseases[1][3][5]. Allergen-specific T lymphocytes are important therapeutic targets for immunomodulation, including allergen-specific immunotherapy and regulatory T cell induction, but are not a single molecular target—“allergen-specific” denotes function within a population, not an individual protein or gene product[1][5]. **Note:** The concept of "allergen-specific T lymphocyte" is functional and population-based, not a discrete molecular entity. It refers to T cells targeted to a given allergen and thus is not a single molecular molecule or classical drug target (like a receptor or enzyme)—this is a limitation for strict target annotation (is_incorrect: true). For structured information, further specificity regarding the T cell receptor (TCR), HLA molecule, or cytokine target is needed.

Other names

Allergen-specific T cellAllergen-reactive T cellAllergen-specific CD4+ T lymphocyteAllergen-specific CD8+ T lymphocyteAllergen-specific T helper cellAllergen-specific regulatory T cell

Induction of T cell anergy or deletion through epitope peptide therapy (rendering T cells unresponsive or neutralized); Targeted immunomodulation (inhibition of effector T cell responses to allergens); Promoting regulatory T cell induction to suppress allergic inflammation[1][3][5]